MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Smartphone-based gait assessment of psychiatric patients on neuroleptics

    S. Hassin-Baer, T. Fay-Karmon, V. Livneh, S. Israeli-Korn, Y. Rubel, K. Tchelet, Z. Yekutieli, M. Linder, H. Yahalom, G. Yahalom (Ramat-Gan, Israel)

    Objective: To characterize gait performance recorded from psychiatric patients on neuroleptics (PPN) and to compare it to Parkinson’s disease (PD) patients and healthy controls (HC).…
  • 2019 International Congress

    Fatigue in Parkinson’s disease and its relation with disease duration and treatment

    D. Nassif, J. Pereira (Rio de Janeiro, Brazil)

    Objective: Identify the presence of fatigue in a population of PD patients, establishing its association with disease duration and treatment. Background: Fatigue is one of…
  • 2019 International Congress

    Auditory processing in young patients of Essential Tremor

    P. Shetty, Y. Belur, R. Yadav, P. Yuvaraj, A. Rajasekaran, N. Shivashankar, S. Hegde, P. Pal (Bangalore, Karnataka, India)

    Objective: The study aims at exploring auditory aspects in young patients with Essential Tremor. Background: Patients with Essential tremor (ET) manifest with motor as well…
  • 2019 International Congress

    Glycopyrrolate as inhalation for treating sialorrhea in Parkinson’s Disease

    L. Velzen, J. Masselink, L. Dorresteijn, K. Movig (Enschede, Netherlands)

    Objective: To evaluate the safety, tolerability and effect of glycopyrrolate inhalations in PD patients with sialorrhea. Background: Sialorrhea is reported in up to 60 percent…
  • 2019 International Congress

    Executive functions correlate with DaT-SPECT laterality in Parkinson’s disease

    T. Alvarez-Avellon, E. Suarez-San Martin, C. Garcia-Fernandez, J. Alvarez-Carriles, R. Ribacoba, F. Cuetos, M. Menendez-Gonzalez (Oviedo, Spain)

    Objective: The aim of this study is to assess whether the impairment of executive functions is associated with the laterality of the affected nigro-striatal pathway…
  • 2019 International Congress

    Clinical and neuroimaging heterogeneity of dementia with Lewy bodies

    A. Chimagomedova, E. Vasenina, O. Levin (Moscow, Russian Federation)

    Objective: To study clinical and neuroimaging features of dementia with Lewy bodies (DLB) for optimal management and prognosis of the disease. Background: Appropriate diagnosis of DLB…
  • 2019 International Congress

    Visuospatial dysfunction correlates with severity of postural instability/gait disturbance symptoms in parkinson’s disease

    H. Jeong, H. Kang (Changwon, Republic of Korea)

    Objective: Investigate the relationship between global and specific cognitive functions and PIGD symptoms in Parkinson’s disease Background: It is well known that cognition and motor…
  • 2019 International Congress

    Vascular risk factors, WMLs and the risk of cognitive impairment in Parkinson disease: A longitudinal study from the Parkinson’s Disease Cognitive Impairment Study (PaCoS) cohort

    A. Luca, R. Monastero, G. Donzuso, R. Baschi, C. Cicero, C. Terravecchia, A. Salerno, M. Zuccarello, M. Davì, V. Restivo, G. Mostile, M. Zappia, A. Nicoletti (Catania, Italy)

    Objective: To identify modifiable vascular risk factors (VRFs) associated with cognitive decline in early PD. Background: The importance of the early identification of modifiable risk…
  • 2019 International Congress

    Identifying subtypes of Mild Cognitive Impairment in Parkinson’s disease using cluster analysis

    D. Pourzinal, JH. Yang, G. Byrne, J. O'Sullivan, L. Mitchell, K. Mcmahon, D. Copland, N. Dissanayaka (St Lucia, Australia)

    Objective: To identify cognitive phenotypes within Parkinson’s disease (PD) and compare them to the current Movement Disorder Society (MDS) diagnostic standards for Mild Cognitive Impairment…
  • 2019 International Congress

    Heart Rate Variability and Cognitive Impairment in Parkinson’s Disease

    C. Terroba-Chambi, D. Vigo, M. Merello (Caba, Argentina)

    Objective: To evaluate the association between the heart rate variability (HRV) and cognitive impairment in PD patients. Background: Emerging evidence suggests an association between cognitive…
  • « Previous Page
  • 1
  • …
  • 49
  • 50
  • 51
  • 52
  • 53
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley